Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Xingzhou Pharma is a Chinese manufacturer focused on gluconate-based products rather than a therapeutics developer. The company was founded in 2003 and produces Glucono Delta Lactone, gluconic acid, and multiple gluconate salts for pharmaceutical-grade, food-grade, and industrial applications. Its business appears to center on R&D, manufacturing, sales, and export of these ingredients, with production based on rice-derived raw materials and proprietary process technology. Xingzhou positions itself as a national high-tech enterprise and a pioneer in China’s food additive industry, and it markets to customers across dozens of export countries and regions. Based on available public information, the company is best characterized as a commercial-stage specialty ingredient and healthcare-related manufacturer rather than a biotech company with a clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Xingzhou Pharma.